Physiological and biochemical parameters of prostacyclin action on the heart and the coronary vasculature.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000227:Adenine Nucleotides / Q000032:analysis; D000241:Adenosine / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002417:Cattle; D003331:Coronary Vessels / Q000187:drug effects / Q000502:physiology*; D000242:Cyclic AMP / Q000378:metabolism; D011464:Epoprostenol / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D009943:Organophosphorus Compounds / Q000032:analysis; D010101:Oxygen Consumption / Q000187:drug effects; D011453:Prostaglandins / Q000494:pharmacology*; D051381:Rats; D014655:Vascular Resistance / Q000187:drug effects
D000227:Adenine Nucleotides; D009943:Organophosphorus Compounds; D011453:Prostaglandins; D011464:Epoprostenol; D000242:Cyclic AMP; D000241:Adenosine; D015056:1-Methyl-3-isobutylxanthine